New ‘Ultrarapid’ genomic testing has reduced the turnaround time for whole genome and transcriptome sequencing in #pancreaticcancer studies from 45 to 14 days. This advancement by OICR researchers could shift the paradigm for cancer treatment and be "game-changing" for patients. bit.ly/3FLtXl1